• Milestone Pharma
    Milestone Pharma
    • About Us
      • Leadership Team
      • Board of Directors
      • Careers
      • Contact Us
    • Areas of Focus
      • Paroxysmal supraventricular tachycardia (PSVT)
      • Atrial Fibrillation with Rapid Ventricular Rate (AFib-RVR)
    • Products
      • CARDAMYST™
    • Pipeline
      • Etripamil
      • Publications
      • Clinical Trials & Patient Access
      • FAQ
    • Investors & Media
      • News & Events
      • Stock Information
      • Financial Information
      • Corporate Governance
      • Investor Resources
Milestone Pharma
Close
  • Milestone Pharma

Products

CARDAMYST™ (etripamil) nasal spray is now approved.

For full Prescribing Information click here.
For Patient Information, click here.
For Instructions for Use, click here.

PATIENTS & CAREGIVERS
Please find patient information here
HEALTHCARE PROFESSIONALS
for more information, click here

PM-etri-00019-2 12/25

Careers | Contact Us | Privacy Policy | Consumer Health Data Privacy Policy | Terms of Use
© Milestone Pharmaceuticals USA, Inc. All Rights Reserved. PM-etri-00010-2 12/25
  • English: United States
    • English: Canada
    • Français (French): Canada

Our website content is tailored by geographical region to comply with local regulatory requirements. Please select which country’s site you’d like to visit.

  • English: United States
  • English: Canada
  • Français (French): Canada